Heidi Ledford works for Nature magazine.
FDA Approves Recombinant Flu Vaccine
The agency's approval of the first seasonal flu vaccine made of recombinant proteins rather than inactivated or weakened virus comes as emergency rooms are clogged with victims of an early and severe flu season
U.S. Fiscal Deal Leaves Science Vulnerable
Congress's decision on January 1 to delay mandatory cuts to agencies, including the NIH and NSF, means administrators must still plan for possible plunges in funding for medical schools and other campuses
FDA Under Pressure to Relax Drug Rules
The drug industry says the antibiotic pipeline is blocked by overly stringent clinical-trial requirements for new treatments
Call to Censor Bird Flu Studies Draws Fire
Critics say controversy over publication of mutant-H5N1 research highlights biosecurity weaknesses
Marijuana Plant Sequenced